Is Your Asthma e-Asthma? New Medicine!

May 25, 2025 | Action Plan, Control Your Asthma!, PEF, symptoms

* e-Asthma is category of moderate and severe asthma

* Patients with e-Asthma have difficulty getting asthma control with inhalers

* e-Asthma responds well to a new type of injected medicine

* In such patients, this new medicine can decrease their asthma attacks and allow them to use less oral steroid.

     e-Asthma is a type of severe asthma that responds well to a new kind of control medicine that you inject under skin, usually monthly.

     Severe Asthma means:

  1. You’ve been on a high dose of inhaled corticosteroid (ICS) and a long-acting bronchodilator or theophylline for the past year; and/or
  2. You’ve been treated with steroids (like Prednisone) by mouth for more than half of the past year.

Wondering what “high dose” ICS means?

 

Definition of high dose*
ICS Age 6 – 12 years Age > 12 yrs
Beclomethasone (Qvar) ≥ 320 mcg/day ≥ 1000 mcg/day
Budesonide (Pulmicort) ≥ 800 mcg/day ≥ 1600 mcg/day
Ciclesonide (Alvesco) ≥ 160 mcg/day ≥ 320 mcg/day
Fluticasone (Flovent) ≥ 500 mcg/day ≥ 1000 mcg/day
Mometasone (Asmanex)  ≥ 500 mcg/day ≥ 800 mcg/day
*European Respiratory Society: Eur Respir J Feb 2014 43:343-373

There is a new type of injectable asthma medicine has been shown to dramatically:

1. Reduce the number of asthma attacks you will have

2. Reduce how much oral steroid (like Prednisone) and ICS you need to stay in control.

You would be likely to get a good response to this new medicine if:

  1. Your eosinophils are elevated in your bloodstream, and
  2. Your allergy testing shows that you are triggered by seasonal allergens.

So, let’s review:

If 

You have been on high dose ICS (see above) or oral steroid for more than half of the year,

AND

You have skin allergy tests that show a problem

THEN

I would recommend having your blood drawn to measure your eosinophil count.

If your eosinophil count is elevated (35-700 IU/mL), you would be a good candidate to try this new type of medicine.

What medications would be considered?

Here is a list of subcutaneous medications that can be ordered for e-Asthma:

 

Omallzumab (Xolair) injected every 2 or 4 weeks depending on your eosinophil count and age

Dupilumab (Dupixent) injected every 2 weeks

Mepolizumab (Nucala) injected every 4 weeks

Benralizumab (Fasenra) injected every 4 weeks for 3 doses, then every 8 weeks.

Tezepelumab (Tezspire) injected every 4 weeks.  This medicine does not require any history of elevated eosinophils or prior testing for allergic asthma.

These medications are quite new and it will take some time for general practitioners to become educated about prescribing them.

But, on Asthmaniac.com they are available RIGHT NOW and if you are suffering from moderate or severe asthma, they could be a really good solution for getting your severe asthma under control.

Asthmaniac IS your online asthma doctor for prescriptions, consultations, education and followup.  Book Today!

#asthmacontrolnow
#telemedicineasthmacare
#backpocketasthmadoc
#asthmaactionplan
#asthmacontroltest
#asthmacontroller
#rescueinhaler
#asthmacovid19
#childrenandasthma
#eprescription
#easthma
#peakexpiratoryflow
#peakflowmeter
#asthmaniac

 

How Can Asthmaniac Address Your Asthma Concerns?

How Can Asthmaniac Address Your Asthma Concerns?

Asthma challenges for Patients Asthma as a disease is not evenly spread across the U.S. There are definitely hotspots as shown in this study:  https://www.aafa.org/asthma-capitals/ Geography doesn’t change the basic problem in the lungs. How do I find out the biggest...

What is an MDI Spacer and Why Do You Need One?

* A spacer is needed to hold your asthma medicine in a cloud until you can pull it into your lungs with a deep breath.

* If you don’t use a spacer with your asthma medicine, it ends up on tongue and on the walls of your throat where it can’t help your asthma and usually causes a yeast infection.

* Spacers should be used with all of your asthma medicine that comes in a metered dose inhaler (MDI).

* Medicine administered by a dry powder inhaler does not require a spacer since the design of the inhaler stirs and suspends the dry powder particles so they can be inhaled deeply.